Karin Kurnik

1.5k total citations
31 papers, 1.0k citations indexed

About

Karin Kurnik is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Karin Kurnik has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 7 papers in Internal Medicine and 6 papers in Surgery. Recurrent topics in Karin Kurnik's work include Platelet Disorders and Treatments (14 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Hemophilia Treatment and Research (13 papers). Karin Kurnik is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Hemophilia Treatment and Research (13 papers). Karin Kurnik collaborates with scholars based in Germany, United States and Israel. Karin Kurnik's co-authors include Christoph Bidlingmaier, Martin Olivieri, Ulrike Nowak‐Göttl, Ralf Knöfler, Karl Reiter, Stephan Weidinger, G. Auerswald, Werner Engl, Birgit M. Reipert and Christine Heller and has published in prestigious journals such as Circulation, PEDIATRICS and Scientific Reports.

In The Last Decade

Karin Kurnik

30 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Kurnik Germany 15 730 190 153 130 118 31 1.0k
Melike Melikoğlu Türkiye 23 173 0.2× 156 0.8× 141 0.9× 94 0.7× 85 0.7× 80 1.9k
Eugenia Biguzzi Italy 18 540 0.7× 85 0.4× 36 0.2× 120 0.9× 207 1.8× 50 929
Janine Campbell Australia 14 206 0.3× 99 0.5× 63 0.4× 81 0.6× 126 1.1× 23 652
Laurens Nieuwenhuizen Netherlands 15 459 0.6× 118 0.6× 32 0.2× 146 1.1× 35 0.3× 50 651
Michelle Lavin Ireland 17 839 1.1× 68 0.4× 37 0.2× 206 1.6× 86 0.7× 63 1.1k
S. Blattner United States 7 314 0.4× 84 0.4× 82 0.5× 102 0.8× 55 0.5× 8 815
Tienan Zhu China 11 163 0.2× 88 0.5× 64 0.4× 50 0.4× 226 1.9× 55 576
Weerapat Owattanapanich Thailand 12 236 0.3× 125 0.7× 44 0.3× 175 1.3× 37 0.3× 72 560
Melanie J. Harrison United States 13 330 0.5× 53 0.3× 107 0.7× 29 0.2× 24 0.2× 18 799
Xiaoxi Zhao China 16 247 0.3× 303 1.6× 74 0.5× 29 0.2× 20 0.2× 79 906

Countries citing papers authored by Karin Kurnik

Since Specialization
Citations

This map shows the geographic impact of Karin Kurnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Kurnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Kurnik more than expected).

Fields of papers citing papers by Karin Kurnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Kurnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Kurnik. The network helps show where Karin Kurnik may publish in the future.

Co-authorship network of co-authors of Karin Kurnik

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Kurnik. A scholar is included among the top collaborators of Karin Kurnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Kurnik. Karin Kurnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carção, Manuel, Susanna Ranta, Heidi Glosli, et al.. (2025). Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group. Haemophilia. 31(3). 419–423.
2.
Gerstl, Lucia, Raphael Weinberger, Florian Heinen, et al.. (2019). Arterial ischemic stroke in infants, children, and adolescents: results of a Germany-wide surveillance study 2015–2017. Journal of Neurology. 266(12). 2929–2941. 18 indexed citations
3.
Gerstl, Lucia, Raphael Weinberger, Florian Heinen, et al.. (2018). Risk factors in childhood arterial ischaemic stroke: Findings from a population-based study in Germany. European Journal of Paediatric Neurology. 22(3). 380–386. 15 indexed citations
4.
Klamroth, Robert, Kate Khair, Karin Kurnik, et al.. (2016). Striving for a Bleed Free World - An Interim Analysis from the AHEAD Study. Haemophilia. 1 indexed citations
5.
Neuner, Bruno, Sylvia von Mackensen, Susanne Holzhauer, et al.. (2016). Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers. BioMed Research International. 2016. 1–8. 6 indexed citations
6.
Kenet, Gili, Christoph Bidlingmaier, Nadja Bogdanova, et al.. (2014). Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A - an Israeli-German multicenter database study. Thrombosis Research. 133(4). 544–549. 4 indexed citations
7.
Halimeh, Susan, Christoph Bidlingmaier, Christine Heller, et al.. (2013). Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study. BioMed Research International. 2013. 1–7. 8 indexed citations
8.
Bidlingmaier, Christoph, Veit Grote, Ulrich Budde, Martin Olivieri, & Karin Kurnik. (2012). Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice. Journal of Thrombosis and Haemostasis. 10(7). 1335–1341. 66 indexed citations
9.
Kurnik, Karin, Ingrid Bartsch, Andrea Maul‐Pavicic, et al.. (2012). Novel mutation in Hermansky–Pudlak syndrome type 2 with mild immunological phenotype. Platelets. 24(7). 538–543. 15 indexed citations
10.
Olivieri, Martin, Karin Kurnik, T. Pfluger, & Christoph Bidlingmaier. (2011). Identification and long‐term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis. Haemophilia. 18(3). 369–374. 63 indexed citations
11.
Iorio, Alfonso, Susan Halimeh, Susanne Holzhauer, et al.. (2010). Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review. Journal of Thrombosis and Haemostasis. 8(6). 1256–1265. 202 indexed citations
12.
Kurnik, Karin, et al.. (2009). New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia. 16(2). 256–262. 126 indexed citations
13.
Wermes, C., Barbara Eifrig, Katharina Holstein, et al.. (2008). Inhibitor-Immunology-Study. Hämostaseologie. 28(S 01). S26–S28. 5 indexed citations
14.
15.
Bidlingmaier, Christoph, Harry N. Magnani, Monika Girisch, & Karin Kurnik. (2006). Safety and Efficacy of Danaparoid (Orgaran<sup>®</sup>) Use in Children. Acta Haematologica. 115(3-4). 237–247. 15 indexed citations
16.
Bidlingmaier, Christoph, et al.. (2006). Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections. Haemophilia. 12(3). 212–217. 25 indexed citations
17.
Bidlingmaier, Christoph, Frauke Bergmann, & Karin Kurnik. (2004). Haemophilia A in two premature infants. European Journal of Pediatrics. 164(2). 70–72. 13 indexed citations
18.
Heinecke, Achim, et al.. (2003). Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thrombosis and Haemostasis. 91(2). 308–314. 24 indexed citations
19.
20.
Zenz, Werner, et al.. (2001). Danaparoid sodium (Orgaran®) in four children with heparin‐induced thrombocytopenia type II. Acta Paediatrica. 90(7). 765–771. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melike Melikoğlu Breakdown of academic impact, for papers by Eugenia Biguzzi Breakdown of academic impact, for papers by Janine Campbell Breakdown of academic impact, for papers by Laurens Nieuwenhuizen Breakdown of academic impact, for papers by Michelle Lavin Breakdown of academic impact, for papers by S. Blattner Breakdown of academic impact, for papers by Tienan Zhu Breakdown of academic impact, for papers by Weerapat Owattanapanich Breakdown of academic impact, for papers by Melanie J. Harrison Breakdown of academic impact, for papers by Xiaoxi Zhao
Rankless by CCL
2026